このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
Clinuvel Pharmaceuticals 配当金
配当金 基準チェック /06
Clinuvel Pharmaceuticals配当を支払う会社であり、現在の利回りは0.34%です。
主要情報
0.3%
配当利回り
8%
配当性向
| 業界平均利回り | 2.8% |
| 次回配当支払日 | n/a |
| 配当落ち日 | n/a |
| 一株当たり配当金 | n/a |
| 一株当たり利益 | AU$0.60 |
| 3年後の配当利回り予想 | 0.6% |
最近の配当金アップデート
Recent updates
If EPS Growth Is Important To You, Clinuvel Pharmaceuticals (ASX:CUV) Presents An Opportunity
Aug 11
Calculating The Intrinsic Value Of Clinuvel Pharmaceuticals Limited (ASX:CUV)
Jun 27Is Now The Time To Put Clinuvel Pharmaceuticals (ASX:CUV) On Your Watchlist?
May 09Estimating The Intrinsic Value Of Clinuvel Pharmaceuticals Limited (ASX:CUV)
Mar 24An Intrinsic Calculation For Clinuvel Pharmaceuticals Limited (ASX:CUV) Suggests It's 41% Undervalued
Nov 18Increases to Clinuvel Pharmaceuticals Limited's (ASX:CUV) CEO Compensation Might Cool off for now
Oct 20Is Clinuvel Pharmaceuticals Limited (ASX:CUV) Trading At A 21% Discount?
Jul 30Clinuvel Pharmaceuticals Limited (ASX:CUV) Shares Could Be 27% Below Their Intrinsic Value Estimate
Feb 27Does Clinuvel Pharmaceuticals (ASX:CUV) Deserve A Spot On Your Watchlist?
Dec 14This Is The Reason Why We Think Clinuvel Pharmaceuticals Limited's (ASX:CUV) CEO Might Be Underpaid
Nov 03A Look At The Fair Value Of Clinuvel Pharmaceuticals Limited (ASX:CUV)
Sep 23Here's Why I Think Clinuvel Pharmaceuticals (ASX:CUV) Might Deserve Your Attention Today
Jul 23With EPS Growth And More, Clinuvel Pharmaceuticals (ASX:CUV) Is Interesting
Apr 10Have Insiders Sold Clinuvel Pharmaceuticals Limited (ASX:CUV) Shares Recently?
Mar 06Earnings Miss: Clinuvel Pharmaceuticals Limited Missed EPS By 41% And Analysts Are Revising Their Forecasts
Feb 27What Is The Ownership Structure Like For Clinuvel Pharmaceuticals Limited (ASX:CUV)?
Feb 20Clinuvel Pharmaceuticals (ASX:CUV) Shareholders Have Enjoyed A Whopping 648% Share Price Gain
Feb 01Estimating The Fair Value Of Clinuvel Pharmaceuticals Limited (ASX:CUV)
Jan 14We Wouldn't Rely On Clinuvel Pharmaceuticals's (ASX:CUV) Statutory Earnings As A Guide
Dec 28
Clinuvel Pharmaceuticals Limited's (ASX:CUV) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Dec 10What You Need To Know About Clinuvel Pharmaceuticals Limited's (ASX:CUV) Investor Composition
Nov 21決済の安定と成長
配当データの取得
安定した配当: CUVはAustralian市場で注目すべき配当金を支払っていないため、支払いが安定しているかどうかを確認する必要はありません。
増加する配当: CUVはAustralian市場で注目すべき配当金を支払っていないため、支払額が増加しているかどうかを確認する必要はありません。
配当利回り対市場
| Clinuvel Pharmaceuticals 配当利回り対市場 |
|---|
| セグメント | 配当利回り |
|---|---|
| 会社 (CUV) | 0.3% |
| 市場下位25% (AU) | 2.7% |
| 市場トップ25% (AU) | 6.7% |
| 業界平均 (Biotechs) | 2.8% |
| 3年後のアナリスト予想 (CUV) | 0.6% |
注目すべき配当: CUVの配当金 ( 0.34% ) はAustralian市場の配当金支払者の下位 25% ( 2.7% ) と比べると目立ったものではありません。
高配当: CUVの配当金 ( 0.34% ) はAustralian市場の配当金支払者の上位 25% ( 6.58% ) と比較すると低いです。
株主への利益配当
収益カバレッジ: CUV Australian市場において目立った配当金を支払っていません。
株主配当金
キャッシュフローカバレッジ: CUV Australian市場において目立った配当金を支払っていません。